RADFORSK has a broad portfolio of companies developing innovative cancer treatments based on excellent research.
Our companies are especially strong within immuno-oncology, photodynamic therapy and radionuclides. RADFORSK has been part of nine initial public offering, IPOs.
Please note that not all of our companies are displayed here.
